Brief: Moberg Pharma Q1 EBIT Rises To SEK 41.8 Mln

Moberg Pharma AB (publ)

19/11/2019 07:10

Nov 19 (Reuters) - Moberg Pharma AB (publ)  MBPH.ST :
    * Q1 EBIT SEK 41.8 MILLION VERSUS SEK 5.0 MILLION YEAR AGO
    * Q1 NET REVENUE SEK 47.8 MILLION VERSUS SEK 15.6 MILLION
YEAR AGO
    * MOST IMPORTANT MARKETS FOR MOB-015 ARE EXPECTED TO US, EU,
JAPAN, CANADA AND CHINA,

Source text for Eikon:  ID:nWkr1gtMWK 
Further company coverage:  MBPH.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))